Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane 4 L six family member 1 (TM4SF1) is a cell surface protein encoded by the TM4SF1 gene, structurally characterized by four hydrophobic transmembrane domains similar to tetraspanins but classified into the L6 family. TM4SF1 is predominantly localized to the plasma membrane and organelles such as lysosomes, and functions as a regulator of cell motility, adhesion, proliferation, and angiogenesis. It is highly expressed in various carcinoma cells and the vascular endothelium of tumors, but shows limited expression in most normal adult tissues. TM4SF1 mediates signal transduction crucial for cancer cell migration, invasion (often via epithelial-mesenchymal transition), angiogenesis, and metastatic reactivation through interactions with integrins (notably α6β1, α6β4), receptor tyrosine kinases (e.g., DDR1), and formation of tetraspanin-enriched microdomains. It is implicated as a prognostic biomarker in cancers and a potential therapeutic target, especially for antibody-based strategies aiming to inhibit pathological angiogenesis and tumor progression. TM4SF1 is also reported as a marker for epithelial progenitor cells and is upregulated in regenerative and inflammatory lung states. No FDA-approved direct TM4SF1-targeted drugs are currently available, but preclinical development is ongoing.
Antibody-dependent cellular cytotoxicity (ADCC); Complement-dependent cytotoxicity (CDC); Inhibition of tumor cell migration, proliferation, and angiogenesis by blocking TM4SF1 function/expression
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane 4 L six family member 1 (TM4SF1).